Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04706026
Other study ID # 2023-0980
Secondary ID Protocol Version
Status Recruiting
Phase N/A
First received
Last updated
Start date June 10, 2024
Est. completion date January 1, 2027

Study information

Verified date June 2024
Source University of Wisconsin, Madison
Contact Elisa Marten, BA
Phone 608-347-1609
Email martenl@surgery.wisc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Inguinal hernia repair-the most common general surgery operation in the U.S.-provides a unique opportunity to improve outcomes for older patients by changing surgical practice. Nearly 80% of inguinal hernia operations are performed under general anesthesia versus 15-20% using local anesthesia, despite the absence of evidence for superiority. The choice of anesthesia has particular implications for older adults because they face substantial short- and long-term risk of cognitive and physical decline after exposure to general anesthesia. Consequently, the American College of Surgeons and the American Geriatrics Society have identified a critical need in surgery: determining which operations have better outcomes when performed under local rather than general anesthesia. Currently, the evidence for choosing an anesthesia technique for inguinal hernia repair in older adults is inconclusive. Several small randomized trials and cohort studies have suggested that using local anesthesia for hernia repair reduces morbidity by one-third, unplanned readmissions by 20%, and operative time and costs by 15% while other studies showed no significant differences. However, there are significant flaws in these studies that severely limit their applicability to older adults: (1) They mainly focused on younger patients with limited comorbidity burden, largely ignoring individuals aged 65 years and older, (2) They did not adequately examine the effects of general anesthesia on cognitive function and quality of life for older adults and their caregivers, (3) They did not consult with stakeholders to identify outcomes relevant to those groups. The current study aims to address these limitations to determine the ideal anesthesia modality for inguinal hernia repair.


Description:

The study rationale is that prior to conducting a multisite randomized trial, it is necessary to identify relevant outcomes, understand barriers to greater use of local anesthesia, test study procedures, and confirm our ability to adequately recruit and randomly assign participants. Additionally, the proposed study will provide the applicant with critical training in the design, conduct, and analysis of clinical trials. This will uniquely position the applicant to change surgical care for older adults. There have been two prior randomized clinical trials that compared local versus general anesthesia for inguinal hernia repair. One study randomized 616 patients in Sweden to local, regional, or general anesthesia. They did not specifically look at older patients but the mean age in each group was 56 years old. They found that the total operative time was five minutes faster for the local anesthesia group (90 versus 95 minutes) the incidence of postoperative pain requiring opioids and catheterization for urinary retention was decreased by 29% for the local compared to general anesthesia group and the rate of unplanned admission was decreased by 19%. A cost-effectiveness analysis conducted by the same group indicated that hospital costs were lower in the local anesthesia group (a difference of €311/$378) and total healthcare costs were also lower (€316/$384). A second trial from Scotland randomized 279 patients to local or general anesthesia, with a mean age of 55 years for both groups. This study did not find a significant difference in operative time, complications, length of stay, pain, or neurocognitive recovery as measured by a battery of tests. However, they did not specifically analyze outcomes in older patients which would tend to dilute the potential benefits of local anesthesia. Equally important, this study focused almost exclusively on healthy patients with smaller hernias, as evidenced by >90% of patients having an American Society of Anesthesiology score of 1 or 2 and a mean total surgical time of 48 minutes for each group. There are several observational studies that compare outcomes from hernia repair under local or general anesthesia, and these mostly suggest that local anesthesia is associated with shorter operative time (5-10 minutes), fewer complications (1-3% reduction), and enhanced quality of life. However, only two of these studies look specifically at outcomes for older adults and both suffer from a poor approach to risk adjustment. Additionally, all the observational studies have a limited assessment of complications and failed to effectively evaluate rates of urinary retention and catheterization after surgery. Urinary retention is the most common complication of general anesthesia after hernia repair and results in considerable discomfort for patients who are catheterized to relieve it. Additionally, when patients do not resolve retention in a timely fashion, it results in the need for unplanned admission which increases hospital costs. The intervention chosen for testing in this study is the choice of anesthesia (local or general) for unilateral inguinal hernia repair. These are the primary methods of anesthesia for inguinal hernia surgery by most surgeons (though some perform the operation under spinal or regional anesthesia, this is rare). Both approaches are used in clinical practice with acceptable known risks and complications. General anesthesia is associated with risks of hypotension, venous thromboembolism, heart attack, stroke, pulmonary dysfunction, cognitive dysfunction, allergic reaction, and malignant hyperthermia. The main risks of local anesthesia include allergic reaction and hypotension (when the anesthetic is improperly injected into a blood vessel).


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date January 1, 2027
Est. primary completion date June 30, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Age >=65 years - Presenting to clinic with a unilateral inguinal hernia that is not incarcerated - Considered suitable for either general or local anesthesia - Willing to complete all study requirements, including follow-up continuing until six months after surgery Exclusion Criteria: - The hernia that the patient is being evaluated for has undergone prior repair - Any contraindications to general anesthesia - Allergies to local anesthesia - Evidence of hernia incarceration or strangulation - Active local or systemic infection that would preclude the use of mesh for hernia repair - Need for concurrent surgical repair at the time of hernia repair - English is not the patient's primary language - Enrollment in other research studies

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Open Inguinal Hernia Repair - Local Anesthesia
Patients in the local anesthesia arm will receive an injection of a 50:50 mix of 1% lidocaine with epinephrine and 0.25% Marcaine at the surgical site (in the skin and subcutaneous layers + beneath the external oblique aponeurosis). Patients in the local arm will also receive intravenous sedation (Propofol or Precedex) and pain medication (morphine or fentanyl) at the discretion of the attending anesthesiologist.
Inguinal Hernia Repair - General Anesthesia
General anesthesia will be administered at the discretion of the anesthesiologist and will involve a combination of inhaled and intravenous anesthesia.

Locations

Country Name City State
United States University of Texas Southwestern Medical Center Dallas Texas
United States Baylor College of Medicine Houston Texas
United States University of Wisconsin Madison Wisconsin

Sponsors (4)

Lead Sponsor Collaborator
University of Wisconsin, Madison American Federation for Aging Research, National Institute on Aging (NIA), The John A. Hartford Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rates of enrollment and percentage of eligible patients enrolled Each week, research assistants will compile running counts of patients screened, found eligible, and enrolled. Through study completion, estimated 2 years
Primary Proportion of participants completing all study visits Assistants will maintain counts of participants who complete each study visit. Through study completion, estimated 2 years
Primary Proportion of missing data At each visit, every study visit will be entered into our electronic database and missing items will have a separate code number. Through study completion, estimated 2 years
Primary Time to complete study evaluations and instruments Assistants will time participants while completing each study research form and will time the entire encounter. Time from beginning to end of completing study instrument, up to 2 hours
Primary Participant satisfaction A 10 point likert scale will measure participant satisfaction. Scores range from 1-10 with higher scores indicating higher satisfaction. At 6 month follow up
Secondary Carolinas Comfort Scale The Carolinas Comfort Scale measures quality of life. Possible scores range from 1-6 for each item, with higher scores indicating increased quality of life. Measured at baseline
Secondary Carolinas Comfort Scale The Carolinas Comfort Scale measures quality of life. Possible scores range from 1-6 for each item, with higher scores indicating increased quality of life. Measured at 48 hours after surgery
Secondary Carolinas Comfort Scale The Carolinas Comfort Scale measures quality of life. Possible scores range from 1-6 for each item, with higher scores indicating increased quality of life. Measured at 2 weeks after surgery
Secondary Carolinas Comfort Scale The Carolinas Comfort Scale measures quality of life. Possible scores range from 1-6 for each item, with higher scores indicating increased quality of life. Measured at 6 months after surgery
Secondary Physical function We will measure the patients' ability to perform their activities of daily living with the 6 item Katz index. This scale is from 0-6, with higher scores indicating more functional independence. Measured at baseline
Secondary Physical function We will measure the patients' ability to perform their activities of daily living with the 6 item Katz index. This scale is from 0-6, with higher scores indicating more functional independence. Measured at 48 hours after surgery
Secondary Physical function We will measure the patients' ability to perform their activities of daily living with the 6 item Katz index. This scale is from 0-6, with higher scores indicating more functional independence. Measured at 2 weeks after surgery
Secondary Physical function We will measure the patients' ability to perform their activities of daily living with the 6 item Katz index. This scale is from 0-6, with higher scores indicating more functional independence. Measured at 6 months after surgery
Secondary Trail Making Test Trail Making Test will be used to measure cognitive function. The time to complete the trail making test is measured, with those taking greater than expected time being considered deficient. Measured at baseline
Secondary Montreal Cognitive Assessment Montreal Cognitive Assessment 5 minute form to measure cognitive function. For the Montreal Cognitive Assessment, the successfully completed skills are added to achieve a final score from 0-30, with higher numbers indicating closer to normal cognitive function. Measured at baseline
Secondary Trail Making Test The Trail Making Test will be used to measure cognitive function. The time to complete the trail making test is measured, with those taking greater than expected time being considered deficient. Measured at 48 hours after surgery
Secondary Montreal Cognitive Assessment Montreal Cognitive Assessment 5 minute form to measure cognitive function. For the Montreal Cognitive Assessment, the successfully completed skills are added to achieve a final score from 0-30, with higher numbers indicating closer to normal cognitive function. Measured at 48 hours after surgery
Secondary Trail Making Test The Trail Making Test will be used to measure cognitive function. The time to complete the trail making test is measured, with those taking greater than expected time being considered deficient. Measured at 2 weeks after surgery
Secondary Montreal Cognitive Assessment Montreal Cognitive Assessment 5 minute form used to measure cognitive function. For the Montreal Cognitive Assessment, the successfully completed skills are added to achieve a final score from 0-30, with higher numbers indicating closer to normal cognitive function. Measured at 2 weeks after surgery
Secondary Trail Making Test Trail Making Test used to measure cognitive function. The time to complete the trail making test is measured, with those taking greater than expected time being considered deficient. Measured at 6 months after surgery
Secondary Montreal Cognitive Assessment Montreal Cognitive Assessment 5 minute form to measure cognitive function. For the Montreal Cognitive Assessment, the successfully completed skills are added to achieve a final score from 0-30, with higher numbers indicating closer to normal cognitive function. Measured at 6 months after surgery
Secondary Delirium The Confusion Assessment Method short form consists of 5 questions, if inattention + acute onset and/or fluctuating course + Disorganized thinking and/or Altered level of consciousness are present this test is considered positive for delirium. Measured at baseline
Secondary Delirium The Confusion Assessment Method short form consists of 5 questions, if inattention + acute onset and/or fluctuating course + Disorganized thinking and/or Altered level of consciousness are present this test is considered positive for delirium. Measured at 48 hours after surgery
Secondary Delirium The Confusion Assessment Method short form consists of 5 questions, if inattention + acute onset and/or fluctuating course + Disorganized thinking and/or Altered level of consciousness are present this test is considered positive for delirium. Measured at 2 weeks after surgery
Secondary Delirium The Confusion Assessment Method short form consists of 5 questions, if inattention + acute onset and/or fluctuating course + Disorganized thinking and/or Altered level of consciousness are present this test is considered positive for delirium. Measured at 6 months after surgery
Secondary Pain level 10 point visual analog scale. Patients indicate on a scale of 0-10 their current level of pain. Higher numbers indicate higher pain. Measured at baseline
Secondary Pain level 10 point visual analog scale. Patients indicate on a scale of 0-10 their current level of pain. Higher numbers indicate higher pain. Measured at 48 hours after surgery
Secondary Pain level 10 point visual analog scale. Patients indicate on a scale of 0-10 their current level of pain. Higher numbers indicate higher pain. Measured at 2 weeks after surgery
Secondary Pain level 10 point visual analog scale. Patients indicate on a scale of 0-10 their current level of pain. Higher numbers indicate higher pain. Measured at 6 months after surgery
Secondary Postoperative complications All complications will be recorded based on VA Surgical Quality Improvement Program definitions. Up to 2 weeks
Secondary Operative time The amount of time the surgery takes (minutes) Time between surgery start and surgery end measured. 1 day of surgery
Secondary Anesthesia time The amount of time in the operating room (minutes) Time spent in operating room. 1 day of surgery
Secondary Recovery time Time spent in the post anesthesia care unit and stepdown units. Time spent in post anesthesia care unit. 1 day of surgery
See also
  Status Clinical Trial Phase
Completed NCT03663478 - Continuous TQL Block for Elective Cesarean Section Phase 4
Completed NCT04513652 - A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution Phase 3
Completed NCT05464862 - The Effect of PPB Using 10, 20 and 30 ml of Lidocaine, Study on Volunteers Phase 4
Completed NCT04690647 - The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement. N/A
Completed NCT03245359 - Pain Management After TKA: Comparison of Short- and Long-term Nerve Blocks N/A
Recruiting NCT06028126 - Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial N/A
Not yet recruiting NCT05815563 - Validation of Peripheral Perfusion Index in Predicting Successful Supraclavicular Brachial Plexus Block in Pediatrics
Completed NCT01418690 - Changes in Tissue Oxygenation Following Regional Anesthesia N/A
Suspended NCT03291691 - Protective Nerve Stimulation in Regional Anesthesia
Not yet recruiting NCT03545516 - Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery Phase 2
Not yet recruiting NCT05038007 - Pain After Lung Cancer Surgery - Comparing Traditional Versus Prolonged Release Nerve Blockades Phase 2
Terminated NCT03672500 - Perineal Local Infiltration Study N/A
Enrolling by invitation NCT06057090 - Do Therapy Dogs Improve Behavior and Reduce Anxiety in Pediatric Dental Patients? N/A
Recruiting NCT05415865 - The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder Phase 3
Recruiting NCT06011005 - Efficacy of Ethyl Chloride Topical Anesthesia Application on the Pain Perception During Intra-oral Injections in Children in Comparison to Benzocaine Gel. N/A
Completed NCT04536311 - Surgical Stabilization of Rib Fractures While Awake or Under Appropriate Sedation by Paravertebral Block N/A
Completed NCT03600454 - The Effect of Anesthesia on Perioperative Muscle Weakness and Neuro-endocrine Stress Response N/A
Recruiting NCT03159338 - Platelet-rich Fibrin on Nerve Regeneration After Bilateral Sagittal Split Osteotomy N/A
Completed NCT02966067 - A Split Mouth Trial to Compare Microneedles vs. Standard Needles in Dental Anaesthetic Delivery N/A
Completed NCT03305666 - Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures Phase 4